Replies to post #7873 on Revance Therapeutics Inc (RVNC)

[Jlinvest01]

Q2 numbers only need to show that trajectory (either sales or volume, but prefereably volume) to break even by eoy '25, is intact. This, and only this will scare them shorts. From 2$ to 4$ is nothing, merely a correction of an overreaction.